People with Alzheimer's disease may benefit from diabetes drug, say scientists.

In trials, the scientists used the experimental drug (Val8)GLP-1 that simulates the activity of a protein called GLP-1 - it helps the body control its response to blood sugar.
Healthy mice were treated with the drug and its effects in the brain were studied.
The researchers found it promoted new brain cells to grow in the hippocampus, an area involved in memory.
But blocking the effect of GLP-1 in the brain made mice perform more poorly on learning and memory tasks, while boosting it with the drug seemed to have no effect on behaviour. There were also no side effects.
(Val8)GLP-1 works in a similar way to two existing drugs, Byetta and Victoza, used to treat Type 2 diabetes.
"This could have huge implications for diseases where brain cells are lost," the paper quoted study leader Professor Christian Holscher as saying.















